 SALT LAKE CITY, Sept. 22, 2021 GLOBE NEWSWIRE -- SINTX Technologies, Inc. NASDAQ: SINT SINTX or the Company, an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of 308,301 awarded by the National Institute of Health NIH to develop a 3-D printed, composite silicon nitride polyetheretherketone SN-PEEK spinal implant. This U.S. government funded research grant addresses the antibacterial and osseointegrative properties of silicon nitride and represents the first NIH grant that has been awarded to SINTX. 